SCHEMBL3164473

SCHEMBL3164473

COc1ncc(-c2sc(C(=O)c3ccc4cc(-c5ccccc5)n(CCCCN)c4c3)cc2CC(=O)NO)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
NTRK1 P04629 4/20 0.35
HDAC8 Q9BY41 2/20 0.34
ITK Q08881 2/20 0.33
NTRK3 Q16288 2/20 0.32
RPS6KA2 Q15349 1/20 0.32
ACLY P53396 1/20 0.32
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
TYK2 P29597 1/20 0.31
JAK3 P52333 1/20 0.31
HDAC1 Q13547 2/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3177728 0.91 NTRK1 (0.36) MTNR1AMTNR1BNTRK1HDAC8NTRK3
SCHEMBL3169972 0.90 NTRK1 (0.35) MTNR1AMTNR1BNTRK1HDAC8NTRK3
SCHEMBL15117543 0.90 KMT2A (0.36) MTNR1AMTNR1BNTRK1NTRK3ACLY
SCHEMBL3171894 0.89 NTRK1 (0.34) MTNR1AMTNR1BNTRK1HDAC8NTRK3
Hydrochloric Acid SCHEMBL3063391 0.89 MTNR1A (0.36) MTNR1AMTNR1BNTRK1NTRK3ACLY
SCHEMBL15117536 0.89 MTNR1A (0.36) MTNR1AMTNR1BNTRK1HDAC8NTRK3
Hydrochloric Acid SCHEMBL3049509 0.88 MTNR1A (0.35) MTNR1AMTNR1BNTRK1HDAC8NTRK3
Hydrochloric Acid SCHEMBL3049516 0.88 MTNR1A (0.35) MTNR1AMTNR1BNTRK1HDAC8NTRK3
SCHEMBL3170821 0.88 NTRK1 (0.38) MTNR1AMTNR1BNTRK1HDAC8ITK
SCHEMBL3173603 0.87 NTRK1 (0.37) MTNR1AMTNR1BNTRK1HDAC8NTRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492428-B2 Small-molecule botulinum toxin inhibitors MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-07-23 US claimed
US-8492428-B2 Small-molecule botulinum toxin inhibitors MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-07-23 US disclosed
US-20100260778-A1 SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100260778-A1 SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS BTD, RAC2, BTN3A1 MTNR1A 992/4885MTNR1B 759/4885NTRK1 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.